Edition:
United Kingdom

Marksans Pharma Ltd (MARK.NS)

MARK.NS on National Stock Exchange of India

21.85INR
11:29am BST
Change (% chg)

Rs1.55 (+7.64%)
Prev Close
Rs20.30
Open
Rs20.55
Day's High
Rs22.10
Day's Low
Rs19.75
Volume
1,699,338
Avg. Vol
1,065,527
52-wk High
Rs40.60
52-wk Low
Rs17.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 2,474.09 0.210
Dec 2,483.65 0.600
Sep 2,690.41 0.479
Jun 2,352.53 0.583
FY 2018 Mar '18 1,993.94 -0.168
Dec 2,184.34 0.410
Sep 2,738.09 0.230
Jun 2,210.56 0.333
FY 2017 Mar '17 1,847.49 -0.152
Dec 2,152.39 0.243
Sep 1,804.26 0.017
Jun 1,867.47 0.110
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 88.58 29.30 32.55
P/E High - Last 5 Yrs. 202.74 43.17 48.11
P/E Low - Last 5 Yrs. 3.32 22.71 23.41
Beta 1.92 0.86 0.87
Price to Sales (TTM) 2.45 6.60 8.44
Price to Book (MRQ) -- 5.12 5.27
Price to Tangible Book (MRQ) -- 5.84 6.74
Price to Cash Flow (TTM) 34.23 23.07 24.12
% Owned Institutions -- 0.87 1.65

Dividends

  Company industry sector
Dividend Yield 0.10 1.43 1.35
Dividend Yield - 5 Year Avg 0.21 1.45 1.37
Dividend 5 Year Growth Rate -- 4.00 4.71
Payout Ratio(TTM) 12.73 42.19 39.59

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 18.37 5.43 13.45
Sales (TTM) vs TTM 1 Yr. Ago -7.87 6.61 8.04
Sales - 5 Yr. Growth Rate 16.63 10.48 10.84
EPS (MRQ) vs Qtr. 1 Yr. Ago 202.90 46.17 48.19
EPS (TTM) vs TTM 1 Yr. Ago -57.13 -- --
EPS - 5 Yr. Growth Rate -- 9.90 10.46
Capital Spending - 5 Yr. Growth Rate 39.36 15.26 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.07 2.18
Current Ratio (MRQ) -- 2.87 2.98
LT Debt to Equity (MRQ) -- 8.87 11.35
Total Debt to Equity (MRQ) -- 12.87 16.04
Interest Coverage (TTM) 8.43 32.47 28.45

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 40.70 52.06 52.36
Gross Margin - 5 Yr. Avg. 38.62 49.67 50.39
EBITD Margin (TTM) 8.13 -- --
EBITD - 5 Yr. Avg 14.77 17.26 12.41
Operating Margin (TTM) 4.05 13.47 5.62
Operating Margin - 5 Yr. Avg. 11.77 13.69 8.00
Pre-Tax Margin (TTM) 4.12 11.82 4.64
Pre-Tax Margin - 5 Yr. Avg. 11.58 14.09 8.28
Net Profit Margin (TTM) 3.06 8.73 1.37
Net Profit Margin - 5 Yr. Avg. 9.34 10.58 4.69
Effective Tax Rate (TTM) 25.61 22.12 22.13
Effective Tax Rate - 5 Yr. Avg. 19.36 22.26 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 11,178,110 928,391,434 819,624,277
Net Income/Employee (TTM) 342,558 105,138,118 92,776,825
Receivable Turnover (TTM) -- 5.84 5.82
Inventory Turnover (TTM) -- 2.57 3.42
Asset Turnover (TTM) -- 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 10.98 10.65
Return on Assets - 5 Yr. Avg. 11.52 12.41 11.77
Return on Investment (TTM) -- 14.23 13.82
Return on Investment - 5 Yr. Avg. 26.35 16.18 15.32
Return on Equity (TTM) -- 15.46 15.24
Return on Equity - 5 Yr. Avg. 27.24 17.07 16.41
  1 Year 3 Year 5 Year
Sales % -14.12 6.79 16.63
EPS (TTM) % -87.88 -50.08 --
Dividend % -58.33 -20.63 --
Note: Units in Millions of US Dollars

Performance for Marksans Pharma Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 21.88 21.40 99 30
13 Week 11.66 10.06 99 42
26 Week -8.15 -14.23 99 43
52 Week -14.00 -24.03 99 11
YTD 20.20 0.60 99 39
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 2.46%
# of Holders: 8
Total Shares Held: 10,069,900
3 Mo. Net Change: -1,588,919
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 1
# Reduced Positions: 6
# Net Buyers: -5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.